Morgan Stanley Pathway Small-Mid Cap Equity ETF MSSM

Medalist Rating as of | See Morgan Stanley Investment Hub

Morningstar’s Analysis MSSM

Will MSSM outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Morgan Stanley Pathway Sm-Md Cp Eq ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MSSM

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 6.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us Dollars

2.24 16M
Cash and Equivalents

Dynatrace Inc Ordinary Shares

0.89 6M
Technology

Ascendis Pharma AS

0.76 5M
Healthcare

KBR Inc

0.69 5M
Industrials

Viasat Inc

0.68 5M
Technology

Haemonetics Corp

0.59 4M
Healthcare

TechnipFMC PLC

0.54 4M
Energy

Life Time Group Holdings Inc

0.53 4M
Consumer Cyclical

Moderna Inc

0.53 4M
Healthcare

Texas Capital Bancshares Inc

0.53 4M
Financial Services

Sponsor Center